Opportunities & Announcements

Find NIAID grant funding opportunity announcements (FOAs) and Notices of Special Interest (NOSIs) below. Subscribe for Email Updates. Also see NIAID Contract Solicitations or Find Funding Outside NIH.

161 Results
Title Sort descending Activity Code Posting Date Expiration Date
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)- PAR-21-155 R15 May 19, 2021 May 08, 2024
Administrative Supplement for Research on Dietary Supplements (Admin Supp, Clinical Trial Not Allowed)- PA-20-227 Supp June 09, 2020 April 16, 2023
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)- PA-20-272 Supp October 13, 2020 July 24, 2023
Administrative Supplements To Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)- PA-21-345 Supp September 10, 2021 September 10, 2024
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)- RFA-AI-21-079 U19 December 23, 2021 June 04, 2022
Biomarker Signatures of TB Infection in Young Children With and Without HIV (R01 Clinical Trial Not Allowed)- RFA-AI-22-015 R01 February 09, 2022 June 09, 2022
Biomedical Data Repository (U24 Clinical Trials Not Allowed)- PAR-20-089 U24 January 17, 2020 May 09, 2023
Biomedical Knowledgebase (U24 Clinical Trials Not Allowed)- PAR-20-097 U24 January 17, 2020 May 09, 2023
CCRP Initiative—Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)- RFA-ES-21-006 R01 June 25, 2021 September 21, 2023
Centers for AIDS Research (P30 Clinical Trial Not Allowed)- PAR-20-106 P30 February 03, 2020 July 29, 2022
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)- PA-21-268 June 30, 2021 July 01, 2024
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)- PAR-20-253 R21 July 07, 2020 May 31, 2023
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)- PAR-20-316 U54 December 21, 2020 September 13, 2023
Data Management and Coordinating Center (DMCC) for the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRC) (U24 Basic Experimental Studies with Humans Required)- RFA-NS-22-020 U24 February 15, 2022 May 25, 2022
Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)- PAR-21-070 R61/R33 November 13, 2020 March 18, 2023
Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)- RFA-AI-22-020 UH2/UH3 April 05, 2022 July 02, 2022
Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)- RFA-AI-22-022 R61/R33 March 10, 2022 August 04, 2022
Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)- PAR-20-298 R01 September 09, 2020 December 08, 2023
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)- PAR-20-107 P30 February 03, 2020 July 29, 2022
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-22-105 R01 May 10, 2022 May 08, 2025
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-22-109 R21 May 10, 2022 May 08, 2025
Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)- PAR-21-109 R21 January 11, 2021 May 08, 2024
Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)- RFA-AI-21-020 U01 March 17, 2021 July 07, 2023
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement, Clinical Trial Optional)- PA-20-135 Supp March 10, 2020 September 08, 2025
Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed)- RFA-AI-22-025 R01 March 29, 2022 August 04, 2022